Suggestions
Anna Turetsky
Principal, Venture Investments at The Mark Foundation for Cancer Research
Anna Turetsky is a highly educated professional with a PhD from Harvard University and a BA from the University of Pennsylvania.
Her expertise lies in venture investments, particularly in the healthcare industry, where she currently serves as Principal at The Mark Foundation for Cancer Research.
Anna has also held positions as a Board Observer at C2i Genomics, Accent Therapeutics, Inc., and as a Board Member at Verseau Therapeutics, showcasing her extensive experience in advisory roles within the biotech and pharmaceutical sectors.